BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16424739)

  • 1. Antithrombotic therapies for sepsis: a need for more studies.
    Minneci PC; Deans KJ; Cui X; Banks SM; Natanson C; Eichacker PQ
    Crit Care Med; 2006 Feb; 34(2):538-41. PubMed ID: 16424739
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL; Downey GP
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.
    Wiedermann CJ; Hoffmann JN; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Keinecke HO; Warren BL; Opal SM;
    Crit Care Med; 2006 Feb; 34(2):285-92. PubMed ID: 16424704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anticoagulants in patients with sepsis.
    Langer M; Riccardi F; Piovella F; Klersy C
    JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023].
    Rublee D; Opal SM; Schramm W; Keinecke HO; Knaub S
    Crit Care; 2002 Aug; 6(4):349-56. PubMed ID: 12225612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are there certified indications for the use of antithrombin III in intensive care].
    Kulka PJ; Tryba M; Lange S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
    Eisele B; Lamy M
    Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing challenges of sepsis research.
    Crowther MA; Marshall JC
    JAMA; 2001 Oct; 286(15):1894-6. PubMed ID: 11597294
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin in severe sepsis--"new" indication of an "old" drug?
    Riess H
    Intensive Care Med; 2000 Jun; 26(6):657-9. PubMed ID: 10945379
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
    Moubarak P; Zilker S; Wolf H; Hofner B; Kneib T; Küchenhoff H; Jauch KW; Hartl WH
    Shock; 2008 Dec; 30(6):634-41. PubMed ID: 18520701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III in patients admitted to intensive care units: a multicenter observational study.
    Messori A; Vacca F; Vaiani M; Trippoli S;
    Crit Care; 2002 Oct; 6(5):447-51. PubMed ID: 12398786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: concerted effect with antithrombin.
    Kamikubo Y; Hamuro T; Matsuda J; Shinya N; Miyamoto S; Funatsu A; Kato H
    Thromb Haemost; 1996 Oct; 76(4):621-6. PubMed ID: 8903006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.
    Baudo F; Caimi TM; de Cataldo F; Ravizza A; Arlati S; Casella G; Carugo D; Palareti G; Legnani C; Ridolfi L; Rossi R; D'Angelo A; Crippa L; Giudici D; Gallioli G; Wolfler A; Calori G
    Intensive Care Med; 1998 Apr; 24(4):336-42. PubMed ID: 9609411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III in animal models of sepsis and organ failure.
    Dickneite G
    Semin Thromb Hemost; 1998; 24(1):61-9. PubMed ID: 9515781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III in patients with severe sepsis: a pharmacokinetic study.
    Ilias W; List W; Decruyenaere J; Lignian H; Knaub S; Schindel F; Keinecke HO; Heinrichs H; Thijs LG
    Intensive Care Med; 2000 Jun; 26(6):704-15. PubMed ID: 10945387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antithrombin III in inhalation injury.
    Latenser BA
    J Burn Care Res; 2009; 30(1):186-8. PubMed ID: 19060754
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.